Literature DB >> 11966739

Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions.

B M Cavaco1, R Domingues, M C Bacelar, H Cardoso, L Barros, L Gomes, M M A Ruas, A Agapito, A Garrão, A A J Pannett, J L Silva, L G Sobrinho, R V Thakker, V Leite.   

Abstract

OBJECTIVE: To determine the spectrum of MEN1 mutations in Portuguese kindreds, and identify mutation-carriers. PATIENTS, DESIGN AND
RESULTS: Six unrelated MEN1 families were studied for MEN1 gene mutations by single-strand conformational polymorphism (SSCP) and DNA sequence analysis of the coding region and exon-intron boundaries of the MEN1 gene. These methods identified 4 different heterozygous mutations in four families: two mutations are novel (mt 1539 delG and mt 655 ims 11 bp) and two have been previously observed (mt 735 del 46p and mt 1656 del C) all resulting in a premature stop codon. In the remaining two families, in whom no mutations or abnormal MEN1 transcripts were detected, segregation studies of the 5' intragenic marker D11S4946 and codon 418 polymorphism in exon 9 revealed two large germline deletions of the MEN1 gene. Southern blot and tumour loss of heterozygosity analysis confirmed and refined the limits of these deletions, which spanned the MEN1 gene at least from: exon 7 to the 3' untranslated region, in one family, and the 5' polymorphic site D11S4946 to exon 9 (obliterating the initiation codon), in the other family. Twenty-six mutant-gene carriers were identified, 6 of which were asymptomatic.
CONCLUSIONS: These results emphasize the importance of the detection of MEN1 germline deletions in patients who do not have mutations of the coding region. Important clues indicating the presence of such deletions may be obtained by segregation studies using the intragenic polymorphisms D11S4946 and at codon 418. The detection of these mutations will help in the genetic counselling of clinical management of the MEN1 families in Portugal.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11966739     DOI: 10.1046/j.1365-2265.2002.01505.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Familial Cushing syndrome due to thymic carcinoids in a multiple endocrine neoplasia type 1 kindred.

Authors:  Xiaohua Li; Jing Su; Li Zhao; Jingcheng Wu; Xiaoying Ding; Fang Fang; Yijie Wu; Haiyan Sun; Yongde Peng
Journal:  Endocrine       Date:  2014-01-23       Impact factor: 3.633

2.  Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.

Authors:  M Ozturk; C Y Chiu; N Akdeniz; S F Jenq; S C Chang; C Y Hsa; T S Jap
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

3.  Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression.

Authors:  Maria Chiara Zatelli; Federico Tagliati; Mauro Di Ruvo; Emilie Castermans; Luigi Cavazzini; Adrian F Daly; Maria Rosaria Ambrosio; Albert Beckers; Ettore degli Uberti
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

4.  Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.

Authors:  Akihiro Sakurai; Miyuki Katai; Wataru Yumita; Kesami Minemura; Kiyoshi Hashizume
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

5.  Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).

Authors:  Elena Pardi; Stefano Mariotti; Natalia S Pellegata; Katiuscia Benfini; Simona Borsari; Federica Saponaro; Liborio Torregrossa; Antonello Cappai; Chiara Satta; Marco Mastinu; Claudio Marcocci; Filomena Cetani
Journal:  Endocr Connect       Date:  2014-11-21       Impact factor: 3.335

6.  Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.

Authors:  Elena Pardi; Simona Borsari; Federica Saponaro; Fausto Bogazzi; Claudio Urbani; Stefano Mariotti; Francesca Pigliaru; Chiara Satta; Fabiana Pani; Gabriele Materazzi; Paolo Miccoli; Lorena Grantaliano; Claudio Marcocci; Filomena Cetani
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

Review 7.  Pituitary tumors in patients with MEN1 syndrome.

Authors:  Luis V Syro; Bernd W Scheithauer; Kalman Kovacs; Rodrigo A Toledo; Francisco J Londoño; Leon D Ortiz; Fabio Rotondo; Eva Horvath; Humberto Uribe
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

8.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

Review 9.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

10.  An unusual phenotype of MEN1 syndrome with a SI-NEN associated with a deletion of the MEN1 gene.

Authors:  Jerena Manoharan; Caroline L Lopez; Karl Hackmann; Max B Albers; Anika Pehl; Peter H Kann; Emily P Slater; Evelin Schröck; Detlef K Bartsch
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.